Annual Report
Total Page：16
File Type：pdf, Size：1020Kb
2016 ANNUAL REPORT 1 | P a g e CONTENTS WELCOME FROM THE CHAIR ............................................................................................................... 3 PSI VOLUNTEERS ............................................................................................................................. 4 TREASURER’S REPORT ..................................................................................................................... 11 MEMBERSHIP REPORT ..................................................................................................................... 13 CONTRACTS / PARTNERSHIP REPORT .................................................................................................. 14 COMMERCIAL REPORT ..................................................................................................................... 16 CAREERS AND ACADEMIC LIAISON COMMITTEE (CALC) REPORT ................................................................ 17 EXTERNAL AFFAIRS REPORT .............................................................................................................. 18 PUBLICATIONS REPORT .................................................................................................................... 19 PSI/EFSPI REGULATORY REPORT ...................................................................................................... 20 SCIENTIFIC COMMITTEE REPORT ........................................................................................................ 22 CONFERENCE 2016 REPORT ............................................................................................................. 23 TRAINING COMMITTEE REPORT ......................................................................................................... 24 SIGS REPORT ................................................................................................................................ 25 PSI EVENTS, 2016 ......................................................................................................................... 29 APPENDIX .................................................................................................................................... 32 2 | P a g e WELCOME FROM THE CHAIR Welcome Welcome to the 2016 Annual Report for PSI which once again highlights the contributions to the PSI committees in the past year. Despite the distractions of the RSS merger debate, services remained unaffected across all the various subcommittees for what has been another busy year for PSI. Please take a few minutes to review the reports from the subcommittees that illustrate the impressive breadth of activities covered in 2016 and join me in giving our Mark Morris thanks to all our volunteers for what has been another successful year for PSI. Glancing at the Treasurer’s report you will see that the past year has been very good for the PSI coffers. The calculated risk of holding the Conference in Berlin certainly paid off, with a record- breaking number of delegates attending, which in turn put PSI’s finances back in a healthy state. Awards The Mick Godley Award is given every year to an unsung hero in one of the PSI committees, in memory of Mick Godley, one of the early stalwarts of PSI in the earlier years with the recipient receiving free attendance at a conference of their choice. The recipient in 2016 was Aaron Dane for his leadership of the subgroup initiative. The RSS/PSI Award for Statistical Excellence in the Pharmaceutical Industry continues to establish itself as a prestigious award with the number of entrants growing every year. This year’s worthy winner was Richard Nixon of Novartis for his work entitled ‘Enhancing decision-making in drug development and using quantitative approaches’. Honorary Membership It was with great pleasure that I had the privilege to award Leslie France with a much-deserved honorary award due to many years of service to PSI. Leslie joins a select group that includes: Jorgen Seldrup, Mick Godley, Andy Grieve, David Morgan, Alan Ebbutt, John Lewis, Steven Senn, James Roger and Alan Phillips. On behalf of the PSI Board of Directors, Mark Morris Chair, Statisticians in the Pharmaceutical Industry 3 | P a g e PSI VOLUNTEERS PSI relies on the contributions of our volunteers, without whom there would be no events and no opportunities to share our ideas with our colleagues or the external world. On behalf of the membership, the BoD is deeply grateful to all those who give time to the society. Board of Directors Name Company, country Role Mark Morris Clinout Solutions, UK PSI Chair Nigel Howitt Covance, UK Commercial Director & Membership Secretary Fiona Brock Quanticate, UK Treasurer Naomi Givens GlaxoSmithKline, UK Partnership Director Craig McIlloney PPD Global, UK Statistical Computing and Website Director Rebecca Sudlow Roche Products Ltd, UK External Affairs & EFSPI Lucy Rowell Roche Products Ltd, UK Conference Chair Mouna Akacha Novartis Pharma AG, Scientific Chair Switzerland Gemma Hodgson Qi Statistics Ltd, UK Training Committee Chair Vicky Marriott Boehringer Ingelheim, UK CALC (Careers & Academic Liaison Committee) Ray Harris Eisai, UK Publications Chair Anna Berglind AstraZeneca, Sweden Regulatory Chair Tim Rolfe GlaxoSmithKline, UK SIGs Chair Training Committee Name Company, country Role Alexander Currie GSK, UK Mark Dixon Roche, UK Mary Elliott Amgen, UK Incoming Chair (from Jan 17) KarolAnne Fitzpatrick Parexel, UK Gemma Hodgson Qi Statistics Ltd. , UK Outgoing Chair (from Jan 17) Caroline Kennedy* Takeda, UK Alison MacLeod Phastar, UK Helen McCafferty PPDI, UK ITIT chair Helen Millns1 GSK, UK Anna Patten Eisai, UK Maria Taboada Astra Zeneca, UK Ingrid Franklin2 Veramed, UK Megan Chilton2 PPDI, UK Margaret Jones2 UCB *maternity leave 1 Left committee during 2016 2 Joined committee during 2016 4 | P a g e Commercial Committee Name Company, country Role Nigel Howitt Covance, UK Commercial Director Anna Passera Consultant Statistician, France Chris Watton Watton Hall, UK Careers and Academic Liaison Committee (CALC) Name Company, country Role Vicky Marriott Boehringer Ingelheim, UK Chair Steve Mallett1 GSK, UK Acting chair (maternity leave cover for Vicky) Claire Brittain1 Eli Lilly, UK School events Kate Taylor1 Amgen, UK MSc prizes Helen Broadhurst1 Astrazeneca, UK Careers event Amanda Darekar Pfizer, UK Careers event, University careers talks Jennifer Pulley Roche, UK Careers event Emma McEntee PAREXEL, UK Careers event, Social media Gail Lynn PPD, UK Website Katharine Thorn2 Eli Lilly, UK School events Cheryl Turkington2 Amgen, UK School events, University prizes Xinyi Zhu2 GSK, UK Careers event Rhian Jacob2 Roche, UK Careers event Kimberley Hacquoil2 GSK, UK MSc funding Tomas Rouse2 Astrazeneca, Sweden MSc funding James Lay-Flurrie2 GSK, UK Rachael Poole2 Quanticate, UK Placement students supporting CALC Hannah Baker1 Eli Lilly, UK CALC support Jemma Greenin2 Eli Lilly, UK CALC support 1 Left committee during 2016 2 Joined committee during 2016 Publications Committee Name Company, country Role Albert Chau Datacision, UK Technical Support for Journal Club Alicia Aylott1 GSK, UK SPIN Editor Anny Stari Astellas, UK News page and eNews Jodie Crawford GSK, UK SPIN sub-editor Kevin Kane Phastar, UK Social Media Laura Steven Numerus, UK Journal Club Mairead North GSK, UK Journal Club Matthew Gibb2 PRA, UK SPIN editor Noormaa Jaumdally Merck, UK ENews editor Ray Harris Eisai, UK Chair and Pharmaceutical Statistics liaison 5 | P a g e Rhiannon Maudsley AstraZeneca, UK SPIN social editor Sarah Bray Amgen, UK Journal Club 1 Left committee during 2016 2 Joined committee during 2016 External Affairs Committee Name Company, country Role Dawn Midwinter GSK, UK Sharon Richards Amgen, UK Rebecca Sudlow2 Roche, UK Chair Jenna Wills MRC CTU, UK 1 Left committee during 2016 2 Joined committee during 2016 PSI/EFSPI Regulatory Committee Name Company, country Role Alun Bedding1 AstraZeneca/Roche, UK Anna Berglind2 AstraZeneca, Sweden Chair, incoming Anne Danniau Grünenthal, Belgium Christoph Gerlinger Bayer, Germany Chair, outgoing, Co-chair, incoming EFSPI Council Member, EFSPI Regulatory Chair Chrissie Fletcher Amgen, UK Chair of CBS, EFSPI Vice President, EFSPI Council Member Daniel Evans Pfizer, UK Erika Daly ICON, UK Florian Voss2 Boehringer-Ingelheim, Germany Frances Lynn BioMarin, UK Jon Blatchford1 Boehringer-Ingelheim, UK Julie Anderson GSK, UK Jürgen Hummel PPD, UK Kaspar Rufibach2 Roche, Switzerland Kerry Gordon Quintiles, UK Lesley France AstraZeneca, UK Co-chair, outgoing Maëva Deniaud2,1 Mdstatconsulting, France Maylis Coste Servier, France EFSPI Council Member Per Larsson1 Novo/Ferring, Denmark Ruthild Sautermeister Medicomp, Germany Antony Sabin2 AstraZeneca, UK 1 Left committee during 2016 2 Joined committee during 2016 6 | P a g e Scientific Committee Name Company, country Role Adam Crisp2 GSK, UK Alicia Aylott2 GSK, UK Andrew Holmes2 Veramed, UK Carly Barnett1 GSK, UK Chris Saville 1 ICON, UK David Lawrence AstraZeneca, UK Emanuela Pozzi Roche, Switzerland Emma Jones 1 Veramed, UK Jennifer Gilbride Sum Of Squares Ltd, UK Jonathan Alsop Numerus, UK Julia Saperia2 MHRA, UK Kate Taylor2 Amgen, UK Conference Vice-Chair Lucy Rowell Roche, UK Conference Chair Lynsey Womersley2 Phastar, UK Maria Efstathiou Quintiles, UK Mouna Akacha Novartis, Switzerland Incoming Scientific Committee Chair Nick Manamley Amgen, UK Outgoing Scientific Committee Chair Paul Terrill CROS NT, UK Rachael Lawrance2 RL Biostatistics Ltd, UK Rachel Moate2 MedImmune, GSK